Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in Ahvaz, Southwest Iran

Iranian Red Crescent Medical Journal

Volumn 14, Issue 8, 2012, Pages 3-

  Assarehzadegan, Mohammad Ali ^a   Boroujerdnia, Mehri Ghafourian ^a   Zandian, Khodamorad ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genotype; Haemophilia A; Hepatitis B; Hepatitis C; Prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POSTTRANSFUSION HEPATITIS; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84864620634     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Alavian S, Adibi P, Zali M. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005;8(2):84-90.
2. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6.
3. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006;9(4):319-23.
4. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007;17(6):425-33.
5. Karimi M, Yarmohammadi H, Ardeshiri R. Inherited coagulation disorders in southern Iran. Haemophilia. 2002;8(6):740-4.
6. Mansour-Ghanaei F, Fallah MS, Shafaghi A, Yousefi-Mashhoor M, Ramezani N, Farzaneh F, et al. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Med Sci Monit. 2002;8(12):CR797-800.
7. Mansouritorghabeh H, Farid Hosseini R, Pourfatollah A, Behjati A. Serological Markers of Blood Borne Viruses among Persons with Combined Factor V & VIII Deficiency. Hepat Mon. 2008;8(3):221-4.
8. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007;28(10):1516-9.
9. Naini M, Derakhshan F, Hoorfar H, Makarian-Rajab F. Analysis of the related factors in hepatitis C virus infection among hemophilic patients in Isfahan, Iran. Hepat Mon. 2007;7(2):59-62.
10. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis. 2008;12(4):387-90.
11. Ghafourian Borojerdnia M, Assarehzadegan MA, Zandian K, Haghirizadeh Rodan M. Prevalence of hepatitis-C virus (HCV) among thalassemia patients in Khuzestan province, Southwest Iran. Pak J Med Sci. 2009;25(1):113-7.
12. Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rahim Rezaee SA. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi J Kidney Dis Transpl. 2009;20(4):681-4.
13. Pham DA, Leuangwutiwong P, Jittmittraphap A, Luplertlop N, Bach HK, Akkarathamrongsin S, et al. High prevalence of Hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allergy Immunol. 2009;27(2-3):153-60.
14. de Paula EV, Goncales NS, Xueref S, Addas-Carvalho M, Gilli SC, Angerami RN, et al. Transfusion-transmitted infections among multi-transfused patients in Brazil. J Clin Virol. 2005;34 Suppl 2:S27-32.
15. Singh H, Pradhan M, Singh RL, Phadke S, Naik SR, Aggarwal R, et al. High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions. Vox Sang. 2003;84(4):292-9.
16. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol. 2006;12(30):4884-7.
17. Ferreira MR, Lonardoni MV, Bertolini DA. Hepatitis C: serological and molecular diagnosis and genotype in haemophilic patients at the Regional Hemocenter of Maringa, Maringa PR Brazil. Haemophilia. 2008.
18. Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia. 2005;11(3):270-5.
19. Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol. 2009;15(45):5647-53.
20. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton). 2003;8(5):256-60.
21. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-7.
22. Farshadpour F, Makvandi M, Samarbafzadeh AR, Jalalifar MA. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Indian J Med Microbiol. 2010;28(1):54-6.
23. Al-Kubaisy WA, Al-Naib KT, Habib M. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia. East Mediterr Health J. 2006;12(1-2):204-10.
24. Bahakim H, Bakir TM, Arif M, Ramia S. Hepatitis C virus antibodies in high-risk Saudi groups. Vox Sang. 1991;60(3):162-4.
25. Barbosa AP, Martins RM, Teles SA, Silva SA, Oliveira JM, Yoshida CF. Prevalence of hepatitis C Virus infection among hemophiliacs in Central Brazil. Mem Inst Oswaldo Cruz. 2002;97(5):643-4.
26. Broumand B, Shamshirsaz AA, Kamgar M, Hashemi R, Aiazi F, Bekheirnia M, et al. Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in tehran: preliminary report from the effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients project. Saudi J Kidney Dis Transpl. 2002;13(4):467-72.
27. Torres MC, Pereira LM, Ximenes RA, Araujo AS, Secaf M, Rodrigues SS, et al. Hepatitis C virus infection in a Brazilian population with sickle-cell anemia. Braz J Med Biol Res. 2003;36(3):323-9.
28. Goedert JJ. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003. Haemophilia. 2005;11(5):516-28.
29. Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood. 2006;107(3):892-7.
30. Al-Kubaisy WA, Al-Naib KT, Habib MA. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. East Mediterr Health J. 2006;12(3-4):264-9.
31. Rikabi A, Bener A, Al-Marri A, Al-Thani S. Hepatitis B and C viral infections in chronic liver disease: a population based study in Qatar. East Mediterr Health J. 2009;15(4):778-84.
32. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009;12(3):225-31.
33. Calderon GM, Gonzalez-Velazquez F, Gonzalez-Bonilla CR, Novelo-Garza B, Terrazas JJ, Martinez-Rodriguez ML, et al. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Transfusion. 2009;49(10):2200-7.
34. Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, et al. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol. 2004;73(2):195-9.
35. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007;13(2):156-63.
36. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004;32(8):493-5.